Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Net loss	$ (29,065)	$ (8,993)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of acquisition-related intangible assets	15,506	15,614
Stock-based compensation plan expense	41,848	33,644
Depreciation and other amortization	28,955	24,290
Gain on sale of cost-method investment	(80)	0
Deferred income tax benefit	(1,900)	(92)
Change in provision for allowances on accounts receivable	(293)	218
Amortization of debt issuance costs	332	310
Amortization of premium on investments	52	58
Fair value adjustment on other investments	(2,576)	0
Gain on other investments	0	(166)
Loss on disposal of equipment	4	38
(Gain) loss on foreign exchange	(370)	292
Changes in operating assets and liabilities:
Accounts receivable	(8,732)	(5,942)
Prepaid expenses and other current assets	(2,279)	(4,612)
Operating lease right-of-use asset, net	(972)	(5,055)
Other assets	(808)	(5,160)
Accounts payable	4,338	808
Accrued expenses	7,129	707
Operating lease liabilities	1,170	5,734
Customer account liabilities	(2,621)	1,391
Deferred revenue	12,918	8,924
Other liabilities	694	(611)
Net cash provided by operating activities	63,250	61,397
Investing activities:
Acquisition of businesses and assets, net of cash acquired	(15,115)	(41,331)
Investment distributions received	161	0
Purchases of other investments	(125)	(7,150)
Issuance of note receivable	0	(2,600)
Purchases of available-for-sale securities	(900)	(10,224)
Proceeds from sales of available-for-sale securities	10,100	10,100
Capital expenditures, including capitalization of software costs	(29,209)	(24,267)
Net cash used in investing activities	(35,088)	(75,472)
Financing activities:
Repurchase of common stock	(50,000)	(10,755)
Repayment of amounts borrowed under revolving credit facility	0	(50,000)
Proceeds from exercise of stock options and employee stock purchase plan	4,760	4,589
Net cash used in financing activities	(45,240)	(56,166)
Effect of exchange rate changes on cash	(2,278)	5,849
Decrease in cash, cash equivalents and restricted cash	(19,356)	(64,392)
Cash, cash equivalents and restricted cash at beginning of period	143,768	201,136
Cash, cash equivalents and restricted cash at end of period	124,412	136,744
Cash and cash equivalents at end of period	117,605	128,188
Cash held for customers at end of period	6,807	8,556
Cash, cash equivalents and restricted cash at end of period	124,412	136,744
Supplemental disclosures of non-cash investing activities:
Issuance of common stock in connection with acquisition	$ 0	$ 8,183